PMID: 9189688Jul 1, 1997Paper

Oral antifungal drug interactions

Dermatologic Clinics
H I Katz, A K Gupta

Abstract

The recent approval of itraconazole and terbafine for the treatment of onychomycosis has launched a new era in the therapeutic management of this previously resistant form of dermatomycoses. These agents represent safe and effective treatments. The clinician should, however, become knowledgeable with the potential drug interactions that are discussed in this article.

References

Feb 1, 1992·The British Journal of Dermatology·A Breckenridge
Mar 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B L Lee, S Safrin
Jan 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R M TuckerD A Stevens
Sep 1, 1992·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·J R PerfectR H Drew
Jan 1, 1991·European Journal of Clinical Pharmacology·M P Gascon, P Dayer
Sep 1, 1991·Antimicrobial Agents and Chemotherapy·S C PiscitelliJ J Schentag
Dec 15, 1990·JAMA : the Journal of the American Medical Association·B P MonahanL R Cantilena
Nov 17, 1990·Lancet·M BlomleyM Weston
Jan 1, 1991·Clinical Pharmacokinetics·G M Shenfield, J M Griffin
Apr 1, 1991·Journal of Clinical Pharmacology·G ApseloffJ D Lazar
Jan 1, 1990·Pharmacotherapy·S F Kowalsky
Jan 1, 1990·European Journal of Clinical Pharmacology·G S HughesT V Ringer
Sep 29, 1990·BMJ : British Medical Journal·J YehC Richardson
Oct 6, 1990·BMJ : British Medical Journal·R J CokerA J Pinching
Feb 1, 1989·Archives of Dermatology·E RampiniP Cardo
Jan 1, 1988·Clinical Pharmacokinetics·T K Daneshmend, D W Warnock
Feb 20, 1967·JAMA : the Journal of the American Medical Association·S I Cullen, P M Catalano
Jul 1, 1995·Journal of the American Academy of Dermatology·P J Neuvonen, R Suhonen
Sep 7, 1995·The New England Journal of Medicine·R S Lees, A M Lees
Apr 1, 1995·Archives of Dermatology·W K Andersen, D S Feingold
Feb 1, 1994·Antimicrobial Agents and Chemotherapy·P L CarverM Atassi
Jul 1, 1994·Clinical Pharmacokinetics·K T KivistöU Klotz
Jan 1, 1994·European Journal of Clinical Pharmacology·H KonishiA Yamaji
Jul 1, 1994·Annals of Emergency Medicine·D L Fett, L F Vukov
May 1, 1994·Australian Family Physician·N Abraham
Sep 1, 1994·Journal of the American Academy of Dermatology·D R Bickers
Dec 1, 1993·Clinical Pharmacokinetics·J G GillumR E Polk
Feb 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J DraytonM G Rinaldi
Oct 1, 1993·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·M BonayE Autret
Sep 13, 1993·Archives of Internal Medicine·A M Baciewicz, F A Baciewicz
Aug 1, 1993·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·S J RossiM R First
Jan 11, 1993·Archives of Internal Medicine·L L Crussell-PorterD W Jaskar
Mar 1, 1993·The American Journal of the Medical Sciences·H D Kerr
Apr 1, 1993·The Pediatric Infectious Disease Journal·K R PhillipsJ A Becker
Jan 1, 1995·Drug Metabolism Reviews·M Spatzenegger, W Jaeger
Jun 1, 1995·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·D I Quinn, R O Day
Mar 1, 1996·Archives of Dermatology·S A TailorN H Shear
May 1, 1996·JAMA : the Journal of the American Medical Association·D Thompson, G Oster
Jul 1, 1996·Clinical Pharmacology and Therapeutics·P J Neuvonen, K M Jalava

❮ Previous
Next ❯

Citations

Jul 30, 1999·Journal of the American Academy of Dermatology·A K GuptaN H Shear
Mar 5, 2003·Journal of Diabetes and Its Complications·Jeffrey M Robbins
Jul 28, 2001·Clinical Pharmacokinetics·D Debruyne, A Coquerel
Sep 3, 2008·The Journal of Hand Surgery·Kara S Nunley, Lynn Cornelius
May 25, 2010·Mycoses·Silvia MenéndezYordana Maqueira
Jan 13, 2001·Dermatologic Clinics·M MoossaviR K Scher
Sep 29, 2004·Clinics in Podiatric Medicine and Surgery·Stephen F Albert, Zak H Weis
Sep 6, 2003·Dermatologic Clinics·H Irving Katz, Aditya K Gupta
Mar 24, 2000·The British Journal of Dermatology·H I Katz
Apr 29, 2003·Journal of the American Academy of Nurse Practitioners·Ellen Davis Jones
Jan 27, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·A K Gupta, N H Shear
May 18, 2007·Journal of the American Podiatric Medical Association·Marc A BrennerJeffrey C Page
Mar 20, 2003·Journal of the American Podiatric Medical Association·Myron A BodmanAngela M Nace
May 17, 2002·Journal of the American Podiatric Medical Association·Aditya K Gupta
Dec 25, 2019·Antimicrobial Agents and Chemotherapy·Kari A MergenhagenThomas A Russo
Dec 17, 2002·Journal of the European Academy of Dermatology and Venereology : JEADV·A K GuptaR Summerbell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the European Academy of Dermatology and Venereology : JEADV
A K Gupta, N Shear
Dermatology : International Journal for Clinical and Investigative Dermatology
A TostiM D Colombo
Journal of the American Academy of Dermatology
M I SingerN Shear
© 2021 Meta ULC. All rights reserved